Pre Tax Income - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epizyme Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Pre-Tax Income
-$207.7m
CAGR 3-Years
-15%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$7.1B
CAGR 3-Years
5%
CAGR 5-Years
14%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.5B
CAGR 3-Years
-39%
CAGR 5-Years
-29%
CAGR 10-Years
-17%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$3.5B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$214.7m
CAGR 3-Years
-55%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4.6B
CAGR 3-Years
-14%
CAGR 5-Years
17%
CAGR 10-Years
19%

See Also

What is Epizyme Inc's Pre-Tax Income?
Pre-Tax Income
-207.7m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Pre-Tax Income amounts to -207.7m USD.

What is Epizyme Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-12%

Over the last year, the Pre-Tax Income growth was 19%. The average annual Pre-Tax Income growth rates for Epizyme Inc have been -15% over the past three years , -12% over the past five years .

Back to Top